View Older Stories View More Recent Stories
-
BMO Capital Sees Attractive Entry Point in Ionis (IONS) Amid Sell-Off; Says NEURO-TTR Study Unaffected By Hold
-
Aeglea BioTherapeutics (AGLE) IPO Opens Flat
-
Silver Wheaton Announces Closing of US$550 Million Bought-deal Common Share Financing
-
Notable Analyst Rating Changes 4/7: (MTH) (GT) (CBRL) Upgraded; (VZ) (HOG) (FFIV) Downgraded
-
First Bank of Canada rate hike draws closer on fiscal stimulus: Reuters poll
-
Silver Wheaton announces closing of US$550 million bought-deal common share financing
-
HP Enterprise (HPE) PT, Estimates Raised at BMO Capital Following Meetings
-
Aeglea BioTherapeutics Announces Pricing of Initial Public Offering
-
After-Hours Stock Movers 04/06: (OLLI) (APOG) (VRX) Higher; (RPTP) (ALDR) (EBAY) Lower (more...)
-
FMC Corporation's Paul Graves to Speak at the BMO Capital Markets 2016 Farm to Market Conference
-
BMO Capital Starts Vertex (VRTX) at Market Perform
-
BMO Capital Starts Ionis Pharmaceuticals (IONS) at Outperform
-
BMO Capital Starts BioMarin Pharmaceutical Inc. (BMRN) at Outperform
-
BMO Capital Starts Intercept Pharmaceuticals (ICPT) at Outperform
-
BMO Capital Starts Incyte (INCY) at Outperform
-
BMO Capital Starts Neurocrine Bio. (NBIX) at Outperform
-
BMO Capital Starts Alexion Pharmaceuticals (ALXN) at Market Perform
-
BMO Capital Reiterates Outperform on Pfizer (PFE) Following Allergan Merger Termination
-
Notable Analyst Rating Changes 4/6: (PHM) (TEF) (CRH) Upgraded; (NVDA) (HIBB) (JCAP) Downgraded
-
Physicians Realty Trust (DOC) Prices Larger 22.5M Common Stock Offering at $17.85/Share
-
Anglo Pacific Group PLC: Notice of 2016 Annual General Meeting
-
After-Hours Stock Movers 04/05: (PLCM) (PFE) (AMGN) Higher; (CREE) (LINE) (WYNN) Lower (more...)
-
BMO Capital Starts Gilead Sciences (GILD) at Market Perform
-
BMO Capital Starts Biogen (BIIB) at Market Perform
-
BMO Capital Starts Amgen (AMGN) at Outperform
-
BMO Capital Starts Celgene (CELG) at Outperform
-
Bank of Montreal Announces Election of Directors
-
Notable Analyst Rating Changes 4/5: (CHMT) (SXL) (ICPT) Upgraded; (LPLA) (LYB) (HRL) Downgraded
-
Valeant (VRX) Could Be on the Verge of a Significant Inflection Point - BMO Capital
-
BMO Capital Downgrades Fifth Third Bancorp (FITB) to Market Perform
-
New Treasury Action Could Block, or Significantly Change Pfizer (PFE)/Allergan (AGN) Deal - BMO Capital
-
BMO Capital Starts Thermon Group Holdings (THR) at Market Perform
-
BMO Capital Starts Ametek Inc. (AME) at Outperform
-
BMO Capital Starts MSC Industrial (MSM) at Market Perform
-
BMO Capital Starts Actuant (ATU) at Market Perform
-
BMO Capital Starts AO Smith (AOS) at Outperform
-
BMO Capital Starts Regal Beloit (RBC) at Outperform
-
BMO Capital Starts Pentair (PNR) at Market Perform
-
BMO Capital Starts Fastenal (FAST) at Market Perform
-
BMO Capital Starts Flowserve Corp. (FLS) at Market Perform
-
BMO Capital Starts IDEX Corp (IEX) at Market Perform
-
BMO Capital Starts WW Grainger (GWW) at Outperform
-
BMO Capital Starts Altra Holdings (AIMC) at Outperform
-
Essex Property Trust Prices $450 Million Senior Unsecured Notes Due April 15, 2026
-
BMO Capital Downgrades Ruckus Wireless (RKUS) to Market Perform Following Takeover
-
Notable Mergers and Acquisitions 4/4: (VA)/(ALK) (RKUS)/(BRCD) (HPE) (HCAC)
-
BMO Capital Remains Sidelined on BlackBerry (BBRY) Following Mixed 4Q
-
Hennessy Capital Acquisition (HCAC), United Subcontractors to Merger in $348.5M Deal
-
Hennessy Capital Acquisition Corp. II and USI Announce Merger Agreement
-
NCE Diversified Flow-Through (16) Limited Partnership determines not to undertake a second closing

